Back to search results
NCT07631559

Pilot Study of an Adapted Partner Navigation Intervention Booster Session for Sustained Healthcare Engagement Among People Who Inject Drugs

Not Yet Recruiting
NAAges 18+Interventional
University of California, San Francisco
~50 participants
Updated 2026-06-08 on ClinicalTrials.gov
What's tested:Partner navigation intervention booster session

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Acceptability of the booster session
Measured over 1 week
+3 more outcomes measured

Conditions

HEPATITIS C (HCV)
Opioid Use Disorder
Substance Use Disorder (SUD)
Drug Use Disorders
Healthcare Access
Harm Reduction

Explore related trials

Hepatitis C InfectionSubstance use disorder

Where it's being run

1 sites across 1 states
California1

Study leadership

  • Meghan Morris, PhD, MPH · PRINCIPAL_INVESTIGATOR · University of California, San Francisco

Who to contact

Meghan Morris, PhD, MPH
[email protected]
415-574-0651
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

18 years of age or older at enrollment
History of injecting drug use
Completed HCV treatment within the past 3 months
Report a primary injecting partner willing to participate
Willing and able to provide informed consent
English or Spanish speaking
Primary injecting partner of an enrolled index participant:
18 years of age or older at enrollment
Willing and able to provide informed consent
English or Spanish speaking
has context menu

Exclusion

Unable to provide informed consent due to cognitive impairment or acute intoxication at the time of enrollment
Previously participated in this study in any capacity

What this trial measures

  • Acceptability of the booster session1 week

    Participant-reported acceptability of the adapted Partner Navigation Intervention booster session, assessed via via brief 3 item questionnaire with 4-point likert response options. Administered to index participants and their injecting partners following session completion.

  • Feasibility: recruitment rateup to 25 weeks

    Proportion of eligible dyads who consent and enroll, calculated as the number enrolled divided by the number approached and screened.

  • Feasibility: retention rateup to 25 weeks

    Proportion of enrolled dyads who complete the booster session, calculated as session completion rate among enrolled participants.

  • Fidelity to session protocol1 hour

    Adherence to the adapted booster session protocol assessed by trained observer using a structured fidelity checklist; reported as proportion of session components delivered as intended.